Insulin Resistance and Vessel Function After Meals: Does Early Intervention Make a Difference?

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Insulin ResistanceImpaired Fasting Glucose
Interventions
DRUG

Nateglinide

Trial Locations (1)

2400

Endothelial laboratory, Cardiology clinic Y-research, H:S Bispebjerg Hospital, Bispebjerg Bakke, Copenhagen

Sponsors

Collaborators (2)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Bayer

INDUSTRY

lead

Atheline Major-Pedersen

OTHER